- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/44 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere
Patent holdings for IPC class C07K 16/44
Total number of patents in this class: 1911
10-year publication summary
|
142
|
143
|
148
|
149
|
157
|
135
|
137
|
129
|
143
|
77
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Yale University | 2543 |
66 |
| Hoffmann-La Roche Inc. | 3796 |
41 |
| Siwa Corporation | 55 |
35 |
| Janssen Pharmaceutica N.V. | 3162 |
34 |
| F. Hoffmann-La Roche AG | 7819 |
31 |
| The Regents of the University of California | 20778 |
31 |
| Memorial Sloan-Kettering Cancer Center | 2046 |
31 |
| ARK Diagnostics, Inc. | 35 |
26 |
| Jiangnan University | 1635 |
22 |
| Northern Bank Limited | 69 |
22 |
| Siemens Healthcare Diagnostics Inc. | 2148 |
20 |
| Regeneron Pharmaceuticals, Inc. | 4727 |
18 |
| Genentech, Inc. | 4110 |
16 |
| MacroGenics, Inc. | 230 |
16 |
| Board of Regents, The University of Texas System | 6117 |
14 |
| Academia Sinica | 958 |
14 |
| Amgen Inc. | 4429 |
13 |
| President and Fellows of Harvard College | 6092 |
13 |
| IDEXX Laboratories, Inc. | 907 |
13 |
| IBC Pharmaceuticals, Inc. | 48 |
12 |
| Other owners | 1423 |